Skip to content

Hearing · house

Examining the FDA’s Regulation of Over-the-Counter Monograph Drugs

2025-04-01 · 14:15

Source status: Scheduled

Committee

Location

2123, Rayburn House Office Building

Video

Witnesses

  1. Mr. Carl D’Ruiz, MPH

    Senior Science, Advocacy, and Business Development Manager for Beauty and Care, North America

  2. Mr. Scott Faber

    Senior Vice President, Government Affairs

  3. Mr. Kevin Menzel

    Member, Board of Directors, Consumer Healthcare Products Association;

  4. Ms. Kim Wezik, MPH

    Director of Advocacy

  5. Mr. Douglas Troutman

    Interim Co-Chief Executive Officer

Official published hearing

Congress.gov explicitly associates this publication with this proceeding.

  • H.Hrg.119

    EXAMINING THE FDA'S REGULATION OF OVER-THE-COUNTER MONOGRAPH DRUGS

    2025-04-01 · GovInfo record 2025-09-04

Congress.gov lists this publication among several possible proceedings.

Documents

Source: https://api.congress.gov/v3/committee-meeting/119/house/118079